Search - tctmd.com

Displaying 61 - 77 of 77

Sort: Relevancy | Date

News Conference News ACC 2017

Live From Washington: ACC 2017, Day Two

Shelley Wood

March 18, 2017

News Conference News ACC 2017

Replacing Aspirin With Low-Dose Rivaroxaban for Post-ACS Therapy Appears Safe

Todd Neale

March 18, 2017

News Conference News ACC 2017

To Stent or Not to Stent? iFR vs FFR Late Breakers at ACC 2017 Seek to Shake Up Treatment Decisions

Caitlin E. Cox

March 14, 2017

News Daily News

Statin-Intolerant Patients Have Significantly Worse Prognosis After MI

Michael O'Riordan

March 13, 2017

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Shelley Wood

March 10, 2017

News Daily News

Updated AUC for Stable Ischemic Heart Disease Seek to Match ‘Appropriateness’ to Current Practice

Caitlin E. Cox

March 10, 2017

News Daily News

‘Inappropriate’ PCI: New York State Efforts Appear to Make a Dent

Caitlin E. Cox

March 07, 2017

News Daily News

Ship Out, Shape Up? Post-ACS Patients Not Getting Enough Physical Activity

Yael L. Maxwell

March 01, 2017

News Daily News

Both Appropriate and Inappropriate ICD Shocks Prompt Substantial Use of Healthcare Resources

Todd Neale

February 16, 2017

News Daily News

Even With Early Invasive Strategy in NSTE ACS, Women Face Poorer Outcomes Than Men

Caitlin E. Cox

January 24, 2017

News Daily News

Conflicting Results: Personal Financial Ties Among Investigators Linked to Positive Trial Findings

Shelley Wood

January 19, 2017

News Daily News

Less Than Half of ACS Patients Are Prescribed High-Potency Statin Therapy

Michael O'Riordan

January 18, 2017

News Features

Be It Resolved: As Evidence Mounts in Favor of a Brain-Heart Connection, Stress Should Be on the Radar During CVD Diagnosis

Yael L. Maxwell

January 16, 2017

News Daily News

High Level of Gut Metabolite Predicts Worse Outcomes in ACS Patients

Michael O'Riordan

January 12, 2016

News Daily News

Ticagrelor More Effective Than Clopidogrel in ACS-With No Extra Bleeding

Kim Dalton

August 30, 2009

CME

Contemporary ACS Management: Why GPIs are Finding Their Way Back Into the Cath Lab

CME

Advertisement

Live From Washington: ACC 2017, Day Two

Replacing Aspirin With Low-Dose Rivaroxaban for Post-ACS Therapy Appears Safe

To Stent or Not to Stent? iFR vs FFR Late Breakers at ACC 2017 Seek to Shake Up Treatment Decisions

Statin-Intolerant Patients Have Significantly Worse Prognosis After MI

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Updated AUC for Stable Ischemic Heart Disease Seek to Match ‘Appropriateness’ to Current Practice

‘Inappropriate’ PCI: New York State Efforts Appear to Make a Dent

Ship Out, Shape Up? Post-ACS Patients Not Getting Enough Physical Activity

Both Appropriate and Inappropriate ICD Shocks Prompt Substantial Use of Healthcare Resources

Even With Early Invasive Strategy in NSTE ACS, Women Face Poorer Outcomes Than Men

Conflicting Results: Personal Financial Ties Among Investigators Linked to Positive Trial Findings

Less Than Half of ACS Patients Are Prescribed High-Potency Statin Therapy

Be It Resolved: As Evidence Mounts in Favor of a Brain-Heart Connection, Stress Should Be on the Radar During CVD Diagnosis

High Level of Gut Metabolite Predicts Worse Outcomes in ACS Patients

Ticagrelor More Effective Than Clopidogrel in ACS-With No Extra Bleeding

Contemporary ACS Management: Why GPIs are Finding Their Way Back Into the Cath Lab

Optimizing Outcomes During and After PCI: From Intravenous to Oral Platelet Inhibition

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content